T-ICD vs S-ICD Shocks: Myocardial Injuries

NCT03458065 — Unknown, 100 participants, Monaldi Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Myocardial Injuries and Hemodynamic Stress Biomarkers: a Comparison Between Transvenous and Subcutaneous ICD Shock

RegistryNCT03458065, acronym MYSTIC
StatusUnknown
Study typeObservational
Enrollment100 (Estimated)
SponsorMonaldi Hospital (Other)
ConditionsICD Shock Myocardial Injuries
InterventionsICD (Device)
Datesstart 2018-04-01 (estimated), primary completion 2018-09-01 (estimated), completion 2019-03-01 (estimated), first posted 2018-03-08, last updated 2018-03-08
Locations1 site in Italy

Related Papers Related Patents Related Grants Related Experts
All trials for ICD Shock Myocardial Injuries All trials of ICD

-Summary

Implantable cardioverter defibrillator (ICD) shocks are associated with a subsequent increased risk of death, and an elevation of cardiac enzymes has been measured after defibrillation testing (DFT). The aim of our study was to investigate the association between S-ICD vs T-ICD shocks and acute cardiac damage in humans, as evaluated by means of sensitive and highly specific circulating biomarkers

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
S-ICDDevice: ICD
T-ICDDevice: ICD
  • ICD (Device): Implantable Cardioverter Defibrillator

+Outcome measures

Primary outcomes

  • myocardial micro-damage [6 months]: degree of myocardial micro-damage, assessed by calculating the variation in the serum levels of high-sensitivity cardiac troponin I (hs-CTnI) and creatine kinase-MB mass concentration (CK-MB mass), measured before and after an S-ICD shock delivered during intraoperative DFT

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

patients who met the criteria for ICD implantation according to the current guidelines

Exclusion Criteria:

\-

+Locations (1)

FacilityCityCountryStatus
Monaldi HospitalNaplesItaly